Suberoylanilide Hydroxamic Acid Treatment Reveals Crosstalks among Proteome, Ubiquitylome and Acetylome in Non-Small Cell Lung Cancer A549 Cell Line

Suberoylanilide hydroxamic acid (SAHA) is a well-known histone deacetylase (HDAC) inhibitor and has been used as practical therapy for breast cancer and non-small cell lung cancer (NSCLC). It is previously demonstrated that SAHA treatment could extensively change the profile of acetylome and proteom...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Quan, Cheng, Zhongyi, Zhu, Jun, Xu, Weiqing, Peng, Xiaojun, Chen, Chuangbin, Li, Wenting, Wang, Fengsong, Cao, Lejie, Yi, Xingling, Wu, Zhiwei, Li, Jing, Fan, Pingsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379480/
https://www.ncbi.nlm.nih.gov/pubmed/25825284
http://dx.doi.org/10.1038/srep09520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379480/
https://www.ncbi.nlm.nih.gov/pubmed/25825284
http://dx.doi.org/10.1038/srep09520

Ejemplares similares